Anzeige
Mehr »
Login
Donnerstag, 15.04.2021 Börsentäglich über 12.000 News von 661 internationalen Medien
Top-Rendite fürs Depot: Superfood und Psychedelika-Medikamente!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QCUH ISIN: SE0014855029 Ticker-Symbol: 8IM1 
Tradegate
15.04.21
18:30 Uhr
13,300 Euro
+0,100
+0,76 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
IMPLANTICA AG SDR Chart 1 Jahr
5-Tage-Chart
IMPLANTICA AG SDR 5-Tage-Chart
RealtimeGeldBriefZeit
13,20013,48018:49

Aktuelle News zur IMPLANTICA Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
17:58Implantica contemplates a private placement of SDRs92STOCKHOLM, April 15, 2021 /PRNewswire/ -- Implantica AG (ticker: IMP A SDB) ("Implantica" or the "Company") has mandated Pareto Securities to evaluate the conditions for a private placement...
► Artikel lesen
SoImplantica-CEO Peter Forsell im AKTIONÄR-Interview: "Ganz besonderes Potenzial"526Im Herbst 2020 ist die Börse mit Implantica aus dem Schweizerischen Zug um einen hochinteressanten Medizintechnik-Wert reicher geworden. Die Gesellschaft führt das Listing allerdings in Schweden durch....
► Artikel lesen
IMPLANTICA Aktie jetzt für 0€ handeln
29.03.Notice of Annual General Meeting of Implantica AG26
24.03.Implantica publishes Annual Report 202022
23.03.Implantica announces a milestone achieved for its implantable medical device RefluxStop348STOCKHOLM, March 23, 2021 /PRNewswire/ -- Implantica AG (publ) today announces that one of the largest hospitals in Europe, University Hospital AKH Vienna, will soon commence a study of RefluxStop...
► Artikel lesen
15.03.Implantica makes headway in Italy and Spain with its medical device RefluxStop349STOCKHOLM, March 15, 2021 /PRNewswire/ -- Implantica AG (publ) today announces that the company will start commercializing RefluxStop on a reimbursed basis in Italy and Spain based on local/regional...
► Artikel lesen
19.02.Implantica presents the fourth quarter 2020 on February 25 at 15:00 CET277STOCKHOLM, Feb. 19, 2021 /PRNewswire/ -- Implantica AG (publ) invites investors to a presentation of the fourth quarter 2020 at 15:00 CET on February 25. The interim report for the fourth...
► Artikel lesen
16.02.Implantica's RefluxStop makes strides in the UK520- Implantica AG (publ) today announces that RefluxStop will start selling in the UK with reimbursement GOTHENBURG, Sweden, Feb. 16, 2021 /PRNewswire/ -- Implantica is now reinforcing...
► Artikel lesen
04.01.Implantica included in Nasdaq First North 25 index46
30.12.20111%-Wette Implantica: Geheimtipp startet durch950Mitte November, in AKTIONÄR-Ausgabe 48/2020, haben sieben Experten sieben verschiedene Aktien mit einem Kurspotenzial von 111 Prozent vorgestellt. Das "Rennen" hat inzwischen AKTIONÄR-Redakteur Michael...
► Artikel lesen
18.11.20Implantica publishes Interim Report Q3, January-September 2020803STOCKHOLM , Nov. 18, 2020 /PRNewswire/ -- "It is with great pleasure that we provide our first quarterly report since listing on Sweden's Nasdaq First North Premier Growth Market on...
► Artikel lesen
12.11.20Implantica presents the third quarter 2020 on November 18, at 10:30 CET24
11.11.20Implantica's RefluxStop trial shows exceptional three-year follow-up result613STOCKHOLM, Nov. 11, 2020 /PRNewswire/ -- Implantica AG (publ) today announced the three-year follow-up results of their medical implant RefluxStop. After three years, results were remarkable...
► Artikel lesen
02.11.20Implantica files pre-submission with FDA for RefluxStop437STOCKHOLM, Nov. 2, 2020 /PRNewswire/ -- Implantica AG (publ) today announced it has completed a pre-submission to the U.S. Food and Drug Administration (FDA) for RefluxStop, a CE-marked medical...
► Artikel lesen
12.10.20XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 12.10.2020417The following instruments on XETRA do have their first trading day 12.10.2020 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag am 12.10.2020 Aktien 1 US7292731020 Plumas Bancorp 2...
► Artikel lesen
30.09.20Exercise of the overallotment option in Implantica and end of stabilisation period344STOCKHOLM, Sept. 30, 2020 /PRNewswire/ -- NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE...
► Artikel lesen
21.09.20Implantica's offering was substantially oversubscribed - trading of the Swedish Depository Receipts on Nasdaq First North Premier Growth Market in Stockholm commences today, 21 September 2020866NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND...
► Artikel lesen
21.09.20Nasdaq Nordic: Nasdaq Stockholm Welcomes Implantica to Nasdaq First North Premier Growth Market1.129Stockholm, September 21, 2020 - Nasdaq (Nasdaq: NDAQ) announces that trading in Implantica AG's shares (short name IMP A SDB) commence today on Nasdaq First North Premier Growth Market. The company...
► Artikel lesen
18.09.20Nasdaq Stockholm AB: Listing of Implantica AG, on Nasdaq First North Premier Growth Market (413/20)245Listing of Implantica AG, on Nasdaq First North Premier Growth Market On request of Implantica AG, company registration number FL-0002629889-3, Nasdaq Stockholm AB has admitted the company's SDRs...
► Artikel lesen
14.09.20Implantica has resolved to shorten the application period of its ongoing offering due to high demand among investors222STOCKHOLM, Sept. 14, 2020 /PRNewswire/ -- On 31 August 2020, Implantica AG[1] ("Implantica", the "Company" or the "Group"), a medtech group with operations within the implantable medical...
► Artikel lesen
Seite:  Weiter >>
23 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,3,6